Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generics Industry Preps For Potential Entry Of Ukraine Into EU

Generics Industry Has Provided Substantial Support Since Russian Invasion

Executive Summary

Generics industry trade group Medicines for Europe has met with Ukrainian government officials to discuss how to plan for any future integration process.

You may also be interested in...



Industry Allies With EBA To Speed Ukraine’s Integration With EU Market

Medicines for Europe has signed a memorandum of understanding with Ukraine’s European Business Association that aims to accelerate the country’s integration into the EU pharmaceutical market.

Efforts Made Across Off-Patent Industry To Secure Ukrainian Medicines Supply

As the invasion of Ukraine continues, trade bodies, manufacturers and individuals across the off-patent industry have stepped up to try and maintain supply of essential medicines to the region.

Insitro’s Daphne Koller On The Marriage Of Biology And Machine Learning At The Company’s Heart

Industry veteran and serial entrepreneur Daphne Koller tells In Vivo about how her company, Insitro, is unleashing the potential of computational biology and machine learning to discover new drug compounds.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB152981

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel